Prostaglandin compounds for the treatment of obesity

Details for Australian Patent Application No. 2003274735 (hide)

Owner Sucampo AG

Inventors Ueno, Ryuji

Agent Davies Collison Cave

Pub. Number AU-B-2003274735

PCT Number PCT/JP03/13453

PCT Pub. Number WO2004/037268

Priority 60/420,336 23.10.02 US

Filing date 22 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 4 December 2008

International Classifications

A61K 31/5575 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): 60/420,336 23.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-B-2003274735

4 December 2008 Application Accepted

  Published as AU-B-2003274735

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003274736-STRUCTURED MATERIAL, MAGNETIC RECORDING MEDIUM UTILIZING THE SAME, AND MAGNETIC RECORDING/REPRODUCING APPARATUS

2003274734-METHOD AND COMPOSITION CONTAINING LATANOPROST FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA